Clinical Trials Browser

Phase 2 × tremelimumab × Endocrine × Clear all

NCT03753919 2026-03-11

DUTHY

Phase 2 Terminated

79 enrolled 25 charts

EndocrineHead & Neck

Thyroid Cancer, Papillary, Thyroid Neoplasms, Adenocarcinoma, Follicular

NCT03095274 2025-01-09

DUNE

Phase 2 Completed

126 enrolled 18 charts

Neuroendocrine Tumors